SeqLL

SeqLL is a life science instrumentation and research services company at the development stage, engaged in the development of scientific assets and novel intellectual property across multiple "omics" fields. We intend to leverage our expertise in True Single Molecule Sequencing ("tSMS") technology to enable researchers and clinicians to make significant contributions to scientific research and development by accelerating the understanding of molecular mechanisms of diseases and fundamental biological processes. We believe that our proprietary sequencing technology platform offers key advantages over existing next-generation sequencing ("NGS") technologies, particularly in emerging applications within biomarker discovery, epigenetics, nucleotide chemistry, forensics, and cell-free nucleic acid analysis. Our mission is to provide researchers with improved genetic tools that allow scientists and physicians to better understand the molecular mechanisms of diseases and underlying biological systems. By assembling top scientists and engineers with extensive expertise in tSMS technology, SeqLL is uniquely positioned to address the gaps left by standard sequencing technologies in RNA transcriptome analysis, specialized DNA analysis, and more.